Pharmaceutical compositions comprising NK1 receptor antagonists and sodium channel blockers

Details for Australian Patent Application No. 2008208918 (hide)

Owner Glaxo Group Limited

Inventors Alvaro, Giuseppe; Large, Charles

Agent Davies Collison Cave

Pub. Number AU-A-2008208918

PCT Pub. Number WO2008/090115

Priority 0701366.7 24.01.07 GB

Filing date 21 January 2008

Wipo publication date 31 July 2008

International Classifications

A61K 31/704 (2006.01)

A61K 31/401 (2006.01) - Proline

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

Event Publications

30 July 2009 PCT application entered the National Phase

  PCT publication WO2008/090115 Priority application(s): WO2008/090115

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008208919-Novel pharmaceutical compositions

2008208896-Pocket sized fluid dispenser